|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Hepatic insulin resistance, metabolice syndrome and cardiovascular disease显示文摘 | Meshkani R Adeli K | 2009 | Clin Biochem2009，42，： | 1 |
| 2 | Palmitate-induced PTP1B expression is mediated by ceramide-JNK and nuclear factorκB(NF-κB)activation显示文摘 | Mohammad Taghvaei N Taheripak G Taghikhani M Meshkani R | 2012 | Cell Signal2012，24，10： | 1 |
| 3 | Hepatic insulin resistance, metabolic syndrome and cardiovascular disease 显示文摘 | MESHKANI R ADELI K | 2009 | Clinical Biochemistry2009，42，1314： | 1 |
| 4 | Detection of familial defective apoB (FDB) mutations in hypercholeste- rolemic children and adolescents by denaturing high perfor- mance liquid chromatography (DHPLC)显示文摘 | NELKEN J MESHKANI R CHAHAL N | 2008 | Clinical Biochem- istry2008，41，6： | 1 |
| 5 | Hepatic insulin resistance, metabolic syn- drome and cardiovascular disease 显示文摘 | Meshkani R Adeli K | 2009 | Clin Biochem2009，42，1314： | 1 |
| 6 | The relationship between homeostasis model assessment and cardiovascular risk factors in Iranian subjects with normal fasting glucose and normal glucose tolerance显示文摘 | Meshkani R Taghikhani M Larijani B | 2006 | Clin Chim Acta2006，371，12： | 1 |
| 7 | Protein tyrosine phosphatase1B (PTP1B) knockdown improves palmitateinduced insulin resistance in C2C12 skeletal muscle cells 显示文摘 | MESHKANI B R TAGHIKHANI M | 2010 | Lipids2010，45，23： | 1 |
| 8 | Hepatic insulin resistance, metabolic syndrome and cardiovascular disease 显示文摘 | MESHKANI R ADELI K | 2009 | Clin Biochem2009，42，1314： | 1 |
| 9 | The relationship between uric acid and metabolic syndrome in normal glucose tolerance and normal fasting glucose subjects显示文摘 | Meshkani R Zargari M Larijani B | 2011 | Acta Diabetol2011，48，1： | 1 |
| 10 | Hepatic insulin resistance, metabolic syndrome and cardiovascular disease 显示文摘 | Meshkani R Adeli K | 2009 | Clin Biochem2009，42，1314： | 1 |
| 11 | The relationship between uric acid and metabolic syndrome in normal glucose tolerance and normal fasting glucose subjects 显示文摘 | Meshkani R Zarqari M Larijani B | 2011 | Acta Diabetol2011，48，1： | 1 |
| 12 | Hepatic insulin resistance, metabolic syndrome and cardiovascular disease显示文摘 | Meshkani R Adeli K | 2009 | Clin Biochem2009，42，1314： | 1 |
| 13 | Hepatic insulin resistance, metabolic syn- drome and cardiovascular disease 显示文摘 | MESHKANI R ADELI K | 2009 | Clin Biochemistry2009，42，1314： | 1 |
| 14 | Palmitate induces SHIP2 expression via the ceramide-mediated ac- tivation of NF-kB, and JNK in skeletal muscle cells显示文摘 | Gorgani-Firuzjaee S Ahmadi S Meshkani R | 2014 | Biochemical and Biophysical Research Communica- tions2014，450，1： | 1 |
| 15 | Estimation of stationary Markov chains 显示文摘 | Billard L Meshkani M R | 1995 | J Am Star Assoc1995，90，429： | 1 |
| 16 | The 1484insG Polymorphism of the PTPN1 Gene Is Associated with Insulin Resistance in an Iranian Population 显示文摘 | Meshkani R Taghikhani M Mosapour A | 2007 | Archives of Medical Research2007，38，5： | 1 |
| 17 | Hepatic insulin resistance,metabolic syndrome and cardiovascular disease显示文摘 | Meshkani R Adeli K | 2009 | Clin Biochem2009，42，1314： | 1 |
| 18 | Hepatic insulin resistance, metabolic syndrome and cardiovascular disease 显示文摘 | Meshkani R Adeli K | 2009 | Clin Biochem2009，42，1314： | 1 |
| 19 | Pre12Ala polymorphism of the peroxisome proliferator-activated receptor-γ2 ( PPARγ- 2) gene is associated with greater insulin sensitivity and decreased risk of type 2 diabetes in an Iranian population显示文摘 | Meshkani R Taghikhani M Larijani B | 2007 | Clin Chem Lab Med2007，45，4： | 1 |
| 20 | Hepatic insulin resistance, metabolic syndrome and cardiovascular disease显示文摘 | MESHKANI R ADELI K | 2009 | Clinical Biochemistry2009，42，1314： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员